AI Threat Assessment · 26 May 2026

Smith & Nephew

Medical Devices
STILL BREATHING
2.8/ 10

“Smith & Nephew spent 167 years perfecting the art of keeping surgeons loyal to their knee implants and wound dressings — the kind of trust-era medical brand where switching means risking a malpractice suit, not just a quarterly earnings miss. The challenge is that AI is earning that same surgical trust faster than they built it, and doing so without requiring a century-long relationship or a sales rep who knows the surgeon's golf handicap.”

Business Model
3.0
Automation Risk
4.5
Moat Strength
2.0
Adaptability
3.5
Need Survival
2.5
AI Threat Level
BUSINESS MODEL REPLACEABILITY

Their revenue comes from physical titanium implants, advanced wound care materials, and robotic surgical systems — products that require FDA approval, sterile manufacturing, and actual atoms arranged in precise configurations. AI can optimise the design and surgical planning, but it cannot materialise a hip replacement out of a prompt.

3.0
WORKFORCE AUTOMATION RISK

AI surgical planning and computer vision diagnostics are replacing the human expertise that used to justify their premium pricing and training programs. The implants still need human hands to install them; the knowledge work that surrounds those hands increasingly doesn't.

4.5
MOAT STRENGTH

Regulatory approval moats run deeper than most software switching costs — their CORI robotics platform and REGENETEN biologics represent years of clinical trials, surgeon training, and FDA validation that cannot be replicated with better code. The trust-era brand compounds when the stakes are irreversible surgical outcomes.

2.0
AI ADAPTABILITY SIGNALS

They're aggressively integrating AI into their CORI robotic knee surgery platform and launching digital surgery ecosystems — rebuilding rather than bolting on, which suggests they understand the stakes. Their $240M investment in surgical robotics shows they're treating this as infrastructure transformation, not feature enhancement.

3.5
WILL THE NEED SURVIVE AI?

Torn ACLs, broken hips, and diabetic ulcers remain stubbornly physical problems requiring physical solutions. AI accelerates the diagnosis and surgical planning but cannot eliminate the need for titanium, collagen, or sterile operating rooms.

2.5
Verdict

“AI makes surgical planning smarter and cheaper, but the patient still needs someone to crack open their knee and bolt in the titanium — Smith & Nephew's regulatory moats and physical manufacturing remain formidable even as their knowledge premiums evaporate. The irony: their 167-year-old brand survives the AI era better than most 7-year-old unicorns, precisely because atoms are harder to automate than bits.”

Scores are based on public information and AI analysis. This is an affectionate roast, not a financial assessment. The best companies use this as a mirror, not a verdict.

Roast another →